Hepatitis B virus (HBV) infection causes chronic hepatitis and has long term complications.
Individuals ever infected with HBV are at risk of viral reactivation under certain …

Molecular epidemiologic studies reveal remarkable differences in the geographical
distribution of hepatitis B virus (HBV) genotypes. The frequency of mutants among HBV …

Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …

At least 10 hepatitis B virus (HBV) genotypes (A to J) with distinct geographic distributions
and several HBV mutants, including precore/core promoter mutations and pre-S/S deletion …

Epidemiology: incidence and prevalence: About 5% of the world's population has chronic
hepatitis B virus (HBV) infection, and nearly 25% of carriers develop chronic hepatitis …

Abstract The Hepatitis B Virus (HBV) has a worldwide distribution and is endemic in many
populations. It is constantly evolving and 10 genotypic strains have been identified with …

Hepatitis B virus (HBV) reactivation associated with various therapeutic interventions is an
important cause of morbidity and mortality in patients with current or resolved HBV infection …

The immunopathogenesis and molecular mechanisms involved during a hepatitis B virus
(HBV) infection have made the approaches for research complex, especially concerning the …

Hepatitis B (HB) vaccination is the most effective method for preventing HB virus (HBV)
infection. Universal HB vaccination containing recombinant HB surface antigens (HBsAg) is …